Masahiro kozuka

Mr. Masahiro kozuka

R&D Division, ARKRAY, Inc., Kyoto, Japan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Cancers
Verified
Journal Article
Open access
PDF file
MKMasahiro kozuka
Masahiro kozuka
FBFrancesca Battaglin
Francesca Battaglin
PJPriya Jayachandran
Priya Jayachandran
JWJingyuan Wang
Jingyuan Wang
HAHIROYUKI ARAI
HIROYUKI ARAI
HLHeinz-Josef Lenz
Heinz-Josef Lenz
Background: Circulating tumor cells (CTCs) are a prognostic marker in patients with metastatic colorectal cancer (mCRC). However, little is known about the characterization of CTCs in mCRC at the single-cell level using RNA sequencing. The purpose of this study was to validate the capability to detect and isolate single CTCs for single-cell RNA sequencing (scRNA-seq) and to identify clinical significance at a single CTC level. Methods: Single CTCs from 27 mCRC patients were collected by CTC-FIND, which is comprised of filter separation and immunomagnetic depletion to collect ultra-pure CTC samples. To address tumor heterogeneity, CTCs were collected without relying on any traditional CTC markers, such as epithelial and mesenchymal cell antigens, and were undertaken by scRNA-seq using SMART-Seq v4. Results: We identified 59 single CTCs which were classified into four groups by epithelial, epithelial-mesenchymal transition (EMT) and stem cell-related gene expression. Patients receiving second or later-line treatment who had EMT gene expressing CTCs had a significantly shorter PFS and OS. Conclusions: Exploiting CTC-FIND with SMART-Seq v4 showed that scRNA-seq of CTCs may shed new insight into tumor heterogeneity of mCRC and that the presence of CTCs expressing EMT-related genes at the single-cell level could have prognostic value in mCRC patients.

2 July 2026 in Journal of Infection and Public Health
Verified
Journal Article
Open access
MKMasahiro kozuka
Masahiro kozuka
YXYining S. Xu
Yining S. Xu
GCGerardo Chowell
Gerardo Chowell
KOKaoru Ogawa
Kaoru Ogawa
YTYoshihiro Takayama
Yoshihiro Takayama
KMKenji Mizumoto
Kenji Mizumoto
Traveler-based surveillance may infer infection risk at places of origin, yet its validity may depend on local testing practices and travel behavior. We evaluated whether the importation risk estimated from travelers can reliably reflect population-based reported case rates across regions of departure within Japan. Using Okinawa Prefecture as a sentinel destination, we compiled laboratory-confirmed COVID-19 cases diagnosed during stays in Okinawa among residents from outside the prefecture and paired them with monthly inbound passenger volumes by origin region. We estimated monthly importation risk (imported cases per passenger) and compared it with reported case rates at origin. We assessed regional and wave-specific heterogeneity and conducted lag sensitivity analyses by shifting origin case time series forward by unshifted (0-day), 7-day, and 14-day shifts before monthly aggregation. Importation risk and origin case rates were positively associated but heterogeneous by region. Overall correlation was robust to timing offsets (Lag 0: 0.60 [0.46-0.71]; Lag 7: 0.56 [0.42-0.68]; Lag 14: 0.48 [0.32-0.61]). High-volume regions contributed most imported diagnoses, yet alignment with origin case rates varied across regions and waves, from consistently strong to weak or inconsistent. Patterns were consistent with heterogeneity in surveillance intensity and travel behavior. Traveler-based importation risk was generally lower than and did not uniformly track origin reported case rates across regions and epidemic waves. It should therefore be interpreted as a complementary sentinel signal rather than a stand-alone proxy for regional disease activity, particularly when routine surveillance is delayed or uneven.